Last updated: 2026-09-16 09:04:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Opko Health Inc. (OPK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,60, with a market capitalisation of $1,16B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,98 to $1,73. This page covers its latest market performance, valuation, price trends and company information.
$1,16B | |
$1,57 | |
$19,20 | |
$0,55 | |
$1,57 | |
-- | |
3,59M | |
-- | |
$1,73 | |
$0,98 | |
-- | |
-- |
Opko Health Inc. (OPK) is trading at $1,60 in pre-market trading as of 2026-09-16 08:01:00, up 1,91% ($0,03) from the previous close of $1,57
Pre-market trading shows how investors are pricing OPK before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Opko Health Inc. (OPK) moved from $1,64 to $1,60, representing a decline of 2,44% ($0,04).
The stock traded between $1,47 and $1,65 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.
The average daily volume was 2,36 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 82,7%
OPK is currently trading at $1,60, placing it 82,7% of the way from its 52-week low of $0,98 to its 52-week high of $1,73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2275 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Opko Health Inc. (OPK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.